PMC6350017_01
Absolute lymphocyte count at various time points during clinical course of the index case.
10.1177_2050313X18823917-fig1.jpg
PMC6350017_01_10.1177_2050313X18823917-fig1.jpg
fig1-2050313X18823917
He remained asymptomatic and under observation for several years but was noted to have rapidly increasing lymphocytosis, progressive lymphadenopathy, symptomatic splenomegaly and thrombocytopenia in 2015 (Table 1 and Figure 1). Approximately two-and-a-half years after initial treatment, thrombocytopenia and rapid increase in lymphocytosis were noted (Table 1 and Figure 1).